These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 3114401)

  • 21. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
    Uchida A; Klein E
    J Natl Cancer Inst; 1986 Mar; 76(3):389-98. PubMed ID: 2419621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypes of human large granular lymphocytes as defined by monoclonal antibodies.
    Rumpold H; Kraft D; Obexer G; Radaszkiewicz T; Majdic O; Bettelheim P; Knapp W; Böck G
    Immunobiology; 1983 Feb; 164(1):51-62. PubMed ID: 6852858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of non-MHC-restricted cytotoxicity by CD45 but not CD3 monoclonal antibodies in patients with large granular lymphoproliferative disease.
    Starling GC; Davidson SE; Nimmo JC; Beard ME; Hart DN
    Clin Exp Immunol; 1989 Dec; 78(3):396-401. PubMed ID: 2532991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noncytotoxic functions of natural killer (NK) cells: large granular lymphocytes (LGL) produce a B cell growth factor (BCGF).
    Procopio AD; Allavena P; Ortaldo JR
    J Immunol; 1985 Nov; 135(5):3264-71. PubMed ID: 3876382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphokine-activated killer cells. Analysis of progenitors and effectors.
    Ortaldo JR; Mason A; Overton R
    J Exp Med; 1986 Oct; 164(4):1193-205. PubMed ID: 3093626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
    Maghazachi AA; Vujanovic NL; Herberman RB; Hiserodt JC
    J Immunol; 1988 Apr; 140(8):2846-52. PubMed ID: 3258622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells.
    Timonen T; Ortaldo JR; Herberman RB
    J Exp Med; 1981 Mar; 153(3):569-82. PubMed ID: 6166701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subsets of human large granular lymphocytes (LGL) exhibit accessory cell functions.
    Scala G; Allavena P; Ortaldo JR; Herberman RB; Oppenheim JJ
    J Immunol; 1985 May; 134(5):3049-55. PubMed ID: 3872328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Swainsonine, an inhibitor of glycoprotein processing, enhances cytotoxicity of large granular lymphocytes.
    Yagita M; Saksela E
    Scand J Immunol; 1990 Mar; 31(3):275-82. PubMed ID: 2108487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell populations in the human early pregnancy decidua: natural killer activity and response to interleukin-2 of CD56-positive large granular lymphocytes.
    Ferry BL; Starkey PM; Sargent IL; Watt GM; Jackson M; Redman CW
    Immunology; 1990 Aug; 70(4):446-52. PubMed ID: 1697563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lysis of fresh human tumor cells by autologous large granular lymphocytes from peripheral blood and pleural effusions.
    Uchida A; Micksche M
    Int J Cancer; 1983 Jul; 32(1):37-44. PubMed ID: 6862692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lymphocyte cytotoxicity against autologous tumor cells and the effect of interferon-beta on their activities. (2) Evaluation of large granular lymphocytes (LGL)].
    Ezaki K; Ito N; Suzuki M; Maruyama F; Kojima H; Sobue R; Matsui T; Ino T; Hirano M
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1246-51. PubMed ID: 3107477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of K562 lysis in autologous LGL and dense T cell cocultures.
    Tsukuda K; Piontek GE; Lewin N; Jondal M; Klein E
    Immunol Lett; 1985; 9(5):291-5. PubMed ID: 3158601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural killer-like activity in human cultured lymphoid cells propagated in the presence of interleukin-2: acquired resistance to prostaglandin E2- or dexamethasone-mediated suppression.
    Suzuki H; Yamashita N; Sato M; Iwata M; Maruyama M; Yano S
    Experientia; 1985 May; 41(5):667-9. PubMed ID: 3873352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
    Ruscetti FW; Mikovits JA; Kalyanaraman VS; Overton R; Stevenson H; Stromberg K; Herberman RB; Farrar WL; Ortaldo JR
    J Immunol; 1986 May; 136(10):3619-24. PubMed ID: 2422259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired release of natural killer cytotoxic factor(s) by peripheral blood lymphocytes in patients with chronic LGL-proliferative disease.
    Eliopoulos GD; Vaiopoulos G; Kyriakou D; Eliopoulos AG; Papadaki H; Katrinakis G; Alexandrakis M
    Haematologica; 1993; 78(4):219-24. PubMed ID: 8294053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro assays to study role of T cell-derived factors on human B lymphocytes should take into consideration inhibiting effect of large granular lymphocyte subset (CD5-,CD16+) that can contaminate B cell preparations.
    Lobo PI; Wright AE
    J Immunol Methods; 1988 Dec; 115(2):239-46. PubMed ID: 3264313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of cytotoxic factor by human large granular lymphocytes during interaction with autologous tumor cells: lysis of fresh human tumor cells.
    Uchida A; Klein E
    J Natl Cancer Inst; 1988 Nov; 80(17):1398-403. PubMed ID: 3262773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel large granular lymphocyte-like cell isolated from IL-2-supplemented murine intestinal lamina propria lymphocyte cultures with potent inhibitory action on lymphocyte proliferation.
    Hörnqvist E; Enerbäck L; Chen XJ; Lycke N
    Cell Immunol; 1993 Apr; 148(1):71-90. PubMed ID: 8495492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation of human natural killer cell cytotoxicity by Salmonella bacteria is an interferon- and interleukin-2-independent process that utilizes CD2 and CD18 structures in the effector phase.
    Tarkkanen J; Saksela E
    Infect Immun; 1991 Aug; 59(8):2767-73. PubMed ID: 1713200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.